This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Stroke, Volume 56, Issue Suppl_1 , Page A154-A154, February 1, 2025. Background:The direct medical costs of stroke in the United States were $84.4 billion from the Medicare Services. billion from the Medicare Services. billion in 2012 and were projected to rise by 157% to $217.3 billion by 2030. 9,523.18) nationwide.
Stroke recovery is a challenging process that extends for months after hospital discharge. Navigating Post-Stroke Recovery at Home: One Patient's Experience A ”mildly impaired” stroke patient with atrial fibrillation who was discharged reported, “I knew my local pharmacist, and they knew my prescriptions.
Stroke, Volume 56, Issue Suppl_1 , Page A63-A63, February 1, 2025. Introduction:Stroke prevalence is highest in adults ages>65 years, the majority of whom are Medicare beneficiaries. Fee-for-Service (FFS) Medicare incentivizes utilization by paying for each service. One found higher LDL levels (81.5 mg/dL vs 78.9
Stroke, Volume 56, Issue Suppl_1 , Page ATP120-ATP120, February 1, 2025. Introduction:AI-based Stroke Care Coordination Platforms (AI-SCCP) have been shown to improve patient transfer decisions and provide access to the highest quality standards of care for all patients. For financially strained PCSs, the retained revenue is critical.
Stroke, Volume 55, Issue Suppl_1 , Page ATP80-ATP80, February 1, 2024. Introduction:In recent years, Medicare Advantage (MA) enrollment in the US has increased dramatically relative to traditional Medicare (TM). of the 16,231 stroke discharges, respectively. Compared with TM, MA beneficiaries were older (77.4
BackgroundStructural racism and rural/urban differences in stroke care affect care delivery and outcomes. Methods and ResultsIn this retrospective study using complete, deidentified inpatient Medicare data (20162019), we identified incident acute ischemic stroke admissions, demographics, and hospitallevel variables.
Stroke, Volume 55, Issue Suppl_1 , Page ATP118-ATP118, February 1, 2024. Background:It is well documented that rehabilitation post-stroke is associated with better functional outcomes, however, in the United States access to post-acute care rehabilitation is becoming increasingly limited.
Stroke, Volume 55, Issue Suppl_1 , Page A5-A5, February 1, 2024. Background:Since 2016, hospitals have been able to document International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) codes for National Institutes of Health Stroke Scale (NIHSS). of hospitals. NIHSS was documented in 40.1%
Stroke, Volume 56, Issue Suppl_1 , Page ATP121-ATP121, February 1, 2025. Simultaneously, the US healthcare system has undergone a period of rapid consolidation with large hospital systems purchasing smaller hospitals and physician practices, an evolution termed vertical integration (VI).
Stroke, Volume 56, Issue Suppl_1 , Page AWMP40-AWMP40, February 1, 2025. Introduction:Rehabilitation is essential to stroke recovery; however, access to rehabilitation varies in the US. We report recent national utilization rates of different rehabilitation disciplines in stroke survivors covered by different payors in the US.
For AIS, we calculated (1) the proportion of White patients at the hospital, (2) the proportional difference in the proportion of White patients between hospital patients and the county, and (3) provider care segregation by the dissimilarity index for ET cases.
Stroke, Volume 55, Issue Suppl_1 , Page AWP108-AWP108, February 1, 2024. However, identifying patients at risk of readmission after stroke is challenging and predictive models have historically not performed well, in part because they often rely on single data sources. The claims dataset included payer and 79 HCC comorbidity codes.
Stroke, Volume 55, Issue Suppl_1 , Page AWP48-AWP48, February 1, 2024. Background:Mortality doubles in stroke patients when Diabetes Mellitus (DM) is present. Participating Get With The Guidelines® (GWTG)-Strokehospitals track EBG data to improve outcomes. 21, 2022, from 51 Wisconsin Coverdell Strokehospitals.
Stroke, Volume 56, Issue Suppl_1 , Page AWP114-AWP114, February 1, 2025. Introduction:Two-thirds of US stroke patients undergo rehabilitation post-discharge with about 20% and 25% receiving care at an inpatient rehabilitation facility (IRF) and skilled nursing facility (SNF), respectively.
Stroke, Volume 55, Issue Suppl_1 , Page AWMP106-AWMP106, February 1, 2024. Background:Medical comorbidities and stroke risk factors only explain a proportion of stroke incidence and outcomes in different populations. Social determinants of health(SDOH)have been associated with incident stroke. 0.96],p=0.001).Patients
Stroke, Volume 55, Issue Suppl_1 , Page AWMP51-AWMP51, February 1, 2024. Background:Medical comorbidities and stroke risk factors explain only a proportion of stroke incidence and outcomes in different populations. The primary outcome measure was discharge to home.
Stroke, Volume 56, Issue Suppl_1 , Page AWMP44-AWMP44, February 1, 2025. Background:The post-acute journey for stroke patients is highly variable. Clinical information on a matched sub-population was linked from the EMR of a 7-hospital certified stroke health system. vs. 28.3%) and the hospital cohort (15.1%
Stroke, Volume 56, Issue Suppl_1 , Page AWMP45-AWMP45, February 1, 2025. Home time is a valid measure of functional recovery in stroke patients that is often used in outcome studies. Patients admitted to IRF or SNF after hospital discharge were confirmed using claims data. The unadjusted 90-day and 1-year mean home time were 15.6
Stroke, Volume 55, Issue Suppl_1 , Page AWP246-AWP246, February 1, 2024. Introduction:The CHA2DS2-VASC score is used to predict stroke in people with atrial fibrillation (AF). CHA2DS2-VASC score (ranging from 0-9) was estimated based on comorbidities documented in hospital data as of the time of acute stroke/TIA.
Stroke, Volume 55, Issue Suppl_1 , Page ATMP22-ATMP22, February 1, 2024. Introduction:Patients who present to a PSC with a large vessel occlusion are often transferred to hospitals with thrombectomy capability. When compared to the remainder of the population, we found no difference in median DIDO for patients on Medicare (-2.0
Stroke, Volume 55, Issue Suppl_1 , Page ATMP15-ATMP15, February 1, 2024. Large vessel occlusion (LVO), a quarter of ischemic strokes, portends poor outcomes. They were more likely insured by Medicare, less by Medicaid, and less likely baseline ambulatory, have a Bachelor’s degree, or own a home, with lower median income.
Stroke, Volume 55, Issue Suppl_1 , Page AWP105-AWP105, February 1, 2024. Introduction:This study evaluates the outcomes of a survivor-centric, navigator-driven, technology-enabled platform supporting survivors (SS) and care partners(CP) in post-stroke recovery. 12.5%, and 90-day readmissions ranging from 18.9%
Stroke: Vascular and Interventional Neurology, Ahead of Print. 1.85) as compared with Medicare beneficiary; having a National Institutes of Health Stroke Scale 10–19 (OR 1.89, 95% CI 1.39–2.50) versus 16.1%;P=0.41). 2.50) or >19 (OR 1.67, 95% CI 1.25–2.26) P=0.06).
Stroke, Volume 55, Issue Suppl_1 , Page AWMP60-AWMP60, February 1, 2024. However, limited information exists on how demographic and clinical factors are associated with social inequities among older patients hospitalized with acute ischemic stroke (AIS) during COVID-19.Methods:We All patients were followed until March 31, 2023.
BackgroundPatients hospitalized with COVID19 from socioeconomically vulnerable communities are at risk for inhospital cardiovascular events. ConclusionsAmong survivors of COVID19 hospitalization, patientlevel social vulnerability was associated with cardiovascular events, explained by increased comorbidities.
Earlier evolocumab initiation reduced the rate of CV death, MI, stroke, hospitalization, or revascularization by 21% in older patients and 14% in younger patients. With evolocumab now covered under Medicare, the drugs once $600 list price isnt what most patients are paying for it. At least insurance isnt an issue.
Stroke, Volume 56, Issue Suppl_1 , Page AWMP58-AWMP58, February 1, 2025. Introduction:The management of acute ischemic stroke over the last three decades has seen an expansive progression in terms of medical and surgical interventions. 4.42, p<0.02). 3.06, p<0.04). 3.06, p<0.04). 3.82, p<0.01).
Stroke, Volume 55, Issue Suppl_1 , Page AWP109-AWP109, February 1, 2024. Background:Utilizing medical claims derived information, we evaluated temporal trends in post-acute care utilization pathways among patients with acute ischemic stroke (AIS) or intracerebral hemorrhage (ICH).Methods:Data and 82.3% (Panel D).Conclusion:Post
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. Study Population includes all patients with an ischemic stroke inpatient admission in 2018 and were continuously enrolled with Medicare FFS for 1 year prior to and following their initial 2018 stroke admission. female and 83.1%
Stroke, Volume 56, Issue Suppl_1 , Page AWP152-AWP152, February 1, 2025. Background:Structural racism and disparities between rural and urban healthcare systems significantly impact stroke care delivery in the United States. vs. 88.6%), stroke certification (5.3% vs. 38.4%), and lower rates of TPA (1.6% for TPA, 1.27
Background:Few studies on care transitions following acute stroke have evaluated whether referral to community-based rehabilitation occurred as part of discharge planning. Participants included adults discharged home following stroke or transient ischemic attack (N=10 702). 2.44]), and having Medicare insurance (1.12 [1.02–1.23])
Stroke, Volume 56, Issue Suppl_1 , Page AWP140-AWP140, February 1, 2025. Background:Maximizing long-term home time (HT) for acute ischemic stroke (AIS) patients has patient-centered and health-system benefits. All claims within 1 year of hospitalization were collated and grouped into corresponding care pathways.
Stroke, Ahead of Print. BACKGROUND:Poststroke depression (PSD) is a treatable and common complication of stroke that is underdiagnosed and undertreated in minority populations.
Stroke, Volume 55, Issue Suppl_1 , Page AWP96-AWP96, February 1, 2024. Introduction:Timely administration of thrombolytic therapy remains the cornerstone of ischemic stroke management and is associated with better functional outcomes. The population served by our hospital is notable for a large socioeconomic range of patients.
BackgroundTransport by mobile stroke units (MSUs), which provide access to computed tomography scanning and intravenous blood pressure medications and thrombolytics, reduces time to treatment and may improve shortterm functional outcomes for patients with acute stroke. women) transported by an MSU for suspected acute stroke, 61.1%
A potentially serious drug interaction between diltiazem and apixaban or rivaroxaban has been reported in US Medicare patients taking these drugs together for atrial fibrillation. It was a retrospective cohort study which included US Medicare benefiaries aged 65 years or more with atrial fibrillation and follow up period was one year.
Despite improvements with current medications and devices, heart failure remains at epidemic proportions and we now have an exciting opportunity for a therapy to improve important, objective outcomes, such as mortality and hospital re-admissions rates. vs. 13.2%, respectively).
A new joint guideline from the American Heart Association (AHA), the American College of Cardiology (ACC) and nine other medical societies reports early diagnosis and treatment of peripheral artery disease is essential to improve outcomes and reduce amputation risk, heart attack, stroke and death for people with Peripheral Artery Disease (PAD).
Stroke, Volume 56, Issue Suppl_1 , Page ATMP37-ATMP37, February 1, 2025. Introduction:Limited studies have examined racial disparities in long-term survival after acute ischemic stroke (AIS) with inconsistent findings. Stroke mortality risk was ~25% higher for White and Black compared to Hispanic and Other (aHR 1.25 (1.24-1.26)).
Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The Society (..)
Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori 1 Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion 2 Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The (..)
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. A backward stepwise regression model (at p<0.05) was used to explore patient demographics, hospital characteristics, and comorbidities significantly associated with EVT use. Individuals with Medicare (OR: 0.39, 95% CI: 0.26‐0.59,
Top 10 Clinical Trials Preventive PCI on Stenosis With Functionally Insignificant Vulnerable Plaque PREVENT (ACC.24) 24) Finerenone Trial to Investigate Efficacy and Safety Superior to Placebo in Patients With HF FINEARTS-HF (ESC Congress 2024 and AHA 2024) Randomized Evaluation of Decreased Usage of Beta-Blockers After AMI REDUCE-AMI (ACC.24)
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content